We are live on
!
Find out more
RI
RTW Investments Portfolio holdings
AUM
$10B
1-Year Est. Return
135.35%
This Fund
S&P 500
This Quarter
Est. Return
+60.02%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$5.96B
AUM Growth
+$1.81B
(+44%)
Cap. Flow
+$286M
Cap. Flow
% of AUM
4.79%
Top 10 Holdings %
Top 10 Hldgs %
47.57%
Holding
116
New
25
Increased
35
Reduced
12
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globus Medical
GMED
|
+$94.3M |
| 2 |
Tarsus Pharmaceuticals
TARS
|
+$70.2M |
| 3 |
C4 Therapeutics
CCCC
|
+$62.3M |
| 4 |
Arvinas
ARVN
|
+$61.8M |
| 5 |
Illumina
ILMN
|
+$61.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$128M |
| 2 |
Baxter International
BAX
|
+$86.6M |
| 3 |
Incyte
INCY
|
+$30M |
| 4 |
Q32 Bio
QTTB
|
+$26.9M |
| 5 |
OraSure Technologies
OSUR
|
+$24.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 94% |
| 2 | Financials | 0.18% |
| 3 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
BioAtla
BCAB
$5.74M
| $340K | 0.01% |
+200
| New | +$334K |
|
102
Seer Inc
SEER
$120M
| $225K | ﹤0.01% |
+4,000
| New | +$254K |
|
|
ADAP
103
DELISTED
Adaptimmune Therapeutics
ADAP
| – | – |
-2,617,626
| Closed | -$20.9M |
|
104
Altimmune
ALT
$599M
| – | – |
-1,334,940
| Closed | -$17.6M |
|
105
Arcturus Therapeutics
ARCT
$211M
| – | – |
-251,236
| Closed | -$10.8M |
|
|
106
Baxter International
BAX
$14.2B
| – | – |
-1,077,268
| Closed | -$86.6M |
|
107
Equillium
EQ
$133M
| – | – |
-1,004,784
| Closed | -$5.8M |
|
|
108
Incyte
INCY
$24.4B
| – | – |
-334,144
| Closed | -$30M |
|
109
uniQure
QURE
$3.22B
| – | – |
-158,479
| Closed | -$5.84M |
|
110
Transmedics
TMDX
$2.91B
| – | – |
-503,266
| Closed | -$6.93M |
|
|
VXRT
111
DELISTED
Vaxart
VXRT
| – | – |
-3,517,345
| Closed | -$23.4M |
|
|
112
Q32 Bio
QTTB
$464M
| – | – |
-139,884
| Closed | -$26.9M |
|
|
AMRS
113
DELISTED
Amyris Inc.
AMRS
| – | – |
-5,161,347
| Closed | -$15.1M |
|
|
LSACU
114
DELISTED
LifeSci Acquisition Corp. Unit 1 COM & 1 WT
LSACU
| – | – |
-500,000
| Closed | -$6.8M |
|
|
MYOK
115
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| – | – |
-936,931
| Closed | -$128M |
|
|
ARYBU
116
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
| – | – |
-500,000
| Closed | -$5.5M |
|
Similar funds
HRCM
RA
GI
IIM
ACA
VPIM
HI
MF
RTW Investments's Q4 2020 Portfolio in Review
As of Q4 2020, RTW Investments held 116 positions worth $5.96B, up 44% from $4.15B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
RTW Investments deployed $286M of net new capital in Q4 2020, opening 25 new positions and adding to 35 existing holdings. Its largest new stake was Globus Medical: 1,640,859 shares worth $107M.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 93% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was OraSure Technologies, an estimated $24.8M trimmed.
- RTW Investments's largest Q4 2020 buy was Globus Medical: 1,640,859 shares worth $107M.
- RTW Investments added most to Illumina in Q4 2020, an estimated $61.2M increase.
- RTW Investments's biggest Q4 2020 reduction was OraSure Technologies, cutting an estimated $24.8M.
- RTW Investments fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $128M.
- RTW Investments's ten largest holdings make up 48% of its $5.96B portfolio in Q4 2020.
- RTW Investments opened 25 new positions and closed 14 in Q4 2020.
- RTW Investments's portfolio value rose 44% quarter-over-quarter to $5.96B.
Based on RTW Investments's 13F filing for Q4 2020, filed 16 Feb 2021.